2018 Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission. Group Acute Leukemia Working Party (ALWP) 1st listed author Saraceni F Journal Oncotarget.
2018 Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Czerw T Journal Cancer.
2018 AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Halaburda K Journal Bone Marrow Transplant.
2017 Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Roth-Guepin G Journal Oncotarget.
2017 Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT. Group Acute Leukemia Working Party (ALWP) Infectious Diseases Working Party (IDWP) 1st listed author Cesaro S Journal Bone Marrow Transplant.
2017 Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT. Group Acute Leukemia Working Party (ALWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Other society 1st listed author Baron F Journal J Hematol Oncol.
2017 Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Shimoni A Journal Biol Blood Marrow Transplant.
2017 Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Poiré X Journal Haematologica
2017 What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? Group Acute Leukemia Working Party (ALWP) 1st listed author Ringdén O Journal J Intern Med.
2017 Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Canaani J Journal Am J Hematol.
2017 Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1. Group Acute Leukemia Working Party (ALWP) 1st listed author Versluis J Journal Blood Adv.
2017 The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis. Group Acute Leukemia Working Party (ALWP) 1st listed author Lorentino F Journal Blood Adv.